Innogen Policy Briefs
Salmon Farming in Scotland (2021)
Joyce Tait, Amy McGoohan, Alan Raybould, Staurt Parris and Kim Hammond
Appropriate Governance of the Life Sciences Series (2008-2012)
Multinational Company Innovation Strategies
Joyce Tait
The Case for Smart Regulation
Joyce Tait, Joanna Chataway and David Wield
Regulating GM Crops: lessons for next generation technologies
Joyce Tait, Ann Bruce, Joanna Chataway, David Wield
Pharmaceutical Futures: Health biotechnology to 2030
Joyce Tait, Joanna Chataway and David Wield
Health Innovation for the world’s poor: Who are the players and what is the game?
Joanna Chataway, Rebecca Hanlin, Joyce Tait and David Wield
Where are Product Development Partnerships (PDPs) headed and how can THeSyS help them get there?
Joanna Chataway, Rebecca Hanlin, Julius Mugwagwa and Lois Muraguri
Interrogating the feasibility of cross-national cooperation in technology governance: the case of biosafety in southern Africa
Julius Mugwagwa
Smarter Regulation of Drug Development: FDA Orphan Products and Fast Track Programmes
Christopher-Paul Milne and Joyce Tait
Pros and Cons of the Precautionary Principle (PP): European Experience with the regulation of GM Crops
Joyce Tait and Joanna Chataway
Cross-national convergence of biosafety systems in Sub-Saharan Africa
Julius Mugwagwa
Governing Synthetic Biology
Joyce Tait
Innogen Working Papers
Technology and Policy Development in Africa NEW!
Norman Clark
New approaches to learning and regulation in medical devices and diagnostics
Smita Srinivas and Dinar Kale
Economics and Public Health: A case for interdisciplinary cohesion in the time of Coronavirus
Pritika Rao and Smita Srinivas
Covid-19 Balancing the needs of public health and the economy
Farah Huzair and Joyce Tait
Behavioural Responses to Pandemic Influenza: Contingency Planning and its Implementation in the UK (2009)
Joyce Tait and Ann Bruce
FINANCING AFRICAN LOCAL PHARMACEUTICAL PRODUCTION
Geoffrey Banda
THE EFFECT OF THE DYNAMICS OF KNOWLEDGE BASE COMPLEXITY ON SCHUMPETERIAN PATTERNS OF INNOVATION: THE UPSTREAM PETROLEUM INDUSTRY
Ali Maleki, Alessandro Rosiello and David Wield
PHARMACEUTICAL EVOLUTION: CLINICAL SELECTION VERSUS INTELLIGENT DESIGN
Jack W. Scannell
FOUR REASONS DRUGS ARE EXPENSIVE, OF WHICH TWO ARE FALSE
AN OPINION
Jack W. Scannell
IT’S NOT STI: IT’S ITS
THE ROLE OF SCIENCE, TECHNOLOGY AND INNOVATION (STI) IN AFRICA’S
DEVELOPMENT STRATEGY
Norman Clark and Andy Frost
THE IMAGINED HEALTH COMMUNITY: NARRATIVES OF SCOTTISH HEALTH AND
INDEPENDENCE
MicheIe Mastroeni, Elisabeth Barlow, James Mittra and David Wield
SCIENCE AND INDUSTRIAL DYNAMICS IN SCOTLAND
Omid Omidvar, Joyce Tait and David Wield
Innogen Reports
Joseph W. Sallmen II and Chris Warkup
Fish farming in Scotland: Optimising its contribution to climate and environmental policies
Amy McGoohan, Joyce Tait, Alan Raybould, Stuart Parris & Kim Hammond
Geoffrey Banda and TIBA Fellows
Report on the bibliometric indicators of innogen (2002-2010)
Ismael Rafols and Rodrigo Costas
Disciplinary portfolio of Innogen by Ismael Rafols
IMPACT project: Recovering breast cancer patients' views about the use of in-vivo biosensors to personalise radiotherapy treatment by Theresa Ikegwuonu, Gill Haddow, Joyce Tait and Ian Kunkler
Independent review on anti-microbial resistance regulation-innovation interactions and the development of anti-microbial drugs and diagnostics for human and animal diseases by Joyce Tait, Ann Bruce, James Mittra, John Purves and Jack Scannell
Independent review on anti-microbial resistance, an evaluation of drug and IVD industry views by Jack Scannell
Independent review on anti-microbial resistance, an evaluation of drug and IVD regulation by John Purves
Independent review on anti-microbial resistance, innovation-regulation interactions in the development of veterinary anti-microbial drugs and diagnostics by Jack Scannell and Ann Bruce
Health Biotechnology to 2030 by Joyce Tait, David Wield, Ann Bruce and Joanna Chataway